155.42
price down icon6.36%   -10.56
after-market Handel nachbörslich: 155.96 0.54 +0.35%
loading
Schlusskurs vom Vortag:
$165.98
Offen:
$164.72
24-Stunden-Volumen:
1.09M
Relative Volume:
0.76
Marktkapitalisierung:
$12.55B
Einnahmen:
$8.19B
Nettoeinkommen (Verlust:
$758.19M
KGV:
16.93
EPS:
9.18
Netto-Cashflow:
$1.06B
1W Leistung:
-14.37%
1M Leistung:
+3.54%
6M Leistung:
-20.68%
1J Leistung:
-50.27%
1-Tages-Spanne:
Value
$154.69
$164.72
1-Wochen-Bereich:
Value
$154.69
$181.59
52-Wochen-Spanne:
Value
$125.10
$328.35

Icon Plc Stock (ICLR) Company Profile

Name
Firmenname
Icon Plc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
39,900
Name
Twitter
@ICONplc
Name
Nächster Verdiensttermin
2025-07-23
Name
Neueste SEC-Einreichungen
Name
ICLR's Discussions on Twitter

Vergleichen Sie ICLR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
ICLR
Icon Plc
155.42 12.91B 8.19B 758.19M 1.06B 9.18
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
448.94 176.13B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
195.17 142.52B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
624.19 51.36B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
113.23 32.64B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
177.49 31.27B 15.50B 1.33B 2.16B 7.34

Icon Plc Stock (ICLR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-24 Hochstufung Robert W. Baird Neutral → Outperform
2025-04-29 Herabstufung JP Morgan Overweight → Neutral
2025-04-14 Herabstufung TD Cowen Buy → Hold
2025-04-10 Herabstufung Barclays Overweight → Equal Weight
2025-03-21 Herabstufung Goldman Buy → Neutral
2025-01-07 Eingeleitet RBC Capital Mkts Outperform
2024-10-24 Herabstufung Robert W. Baird Outperform → Neutral
2024-10-14 Eingeleitet Redburn Atlantic Neutral
2024-09-18 Eingeleitet Leerink Partners Outperform
2024-06-06 Eingeleitet Goldman Buy
2023-12-15 Eingeleitet Truist Buy
2023-09-13 Eingeleitet TD Cowen Outperform
2023-01-17 Hochstufung Barclays Equal Weight → Overweight
2023-01-13 Hochstufung Barclays Equal Weight → Overweight
2022-11-09 Hochstufung BofA Securities Neutral → Buy
2022-09-07 Eingeleitet UBS Buy
2022-08-25 Eingeleitet Credit Suisse Neutral
2022-05-24 Eingeleitet Guggenheim Buy
2022-04-25 Herabstufung Wells Fargo Overweight → Equal Weight
2022-04-12 Hochstufung Deutsche Bank Hold → Buy
2021-09-27 Hochstufung JP Morgan Neutral → Overweight
2021-08-05 Fortgesetzt Credit Suisse Outperform
2021-07-23 Hochstufung Citigroup Neutral → Buy
2021-07-14 Eingeleitet Citigroup Neutral
2021-04-13 Fortgesetzt BofA Securities Neutral
2021-04-01 Hochstufung Wells Fargo Equal Weight → Overweight
2021-03-08 Hochstufung Robert W. Baird Neutral → Outperform
2021-03-03 Eingeleitet Barclays Equal Weight
2021-03-01 Hochstufung UBS Neutral → Buy
2021-02-26 Hochstufung Truist Hold → Buy
2020-07-24 Herabstufung BofA Securities Buy → Neutral
2020-04-20 Herabstufung Robert W. Baird Outperform → Neutral
2020-03-26 Hochstufung Barclays Equal Weight → Overweight
2020-03-02 Eingeleitet Deutsche Bank Hold
2020-01-27 Herabstufung SunTrust Buy → Hold
2020-01-08 Eingeleitet Wells Fargo Equal Weight
2020-01-07 Eingeleitet Citigroup Neutral
2019-09-23 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2019-07-26 Hochstufung UBS Sell → Neutral
2019-01-25 Hochstufung Mizuho Neutral → Buy
2018-10-26 Hochstufung Evercore ISI In-line → Outperform
2018-10-09 Eingeleitet UBS Sell
2018-04-03 Herabstufung Evercore ISI Outperform → In-line
2018-02-15 Bestätigt Mizuho Neutral
2018-01-19 Eingeleitet Evercore ISI Outperform
2017-10-27 Bestätigt Barclays Equal Weight
2017-09-11 Eingeleitet BofA/Merrill Buy
2017-07-31 Hochstufung SunTrust Hold → Buy
2017-07-27 Bestätigt Mizuho Neutral
2017-06-29 Hochstufung Jefferies Hold → Buy
Alle ansehen

Icon Plc Aktie (ICLR) Neueste Nachrichten

pulisher
Aug 01, 2025

Fund Update: First Pacific Advisors, LP added 417,173 shares of ICON PLC ($ICLR) to their portfolio - Quiver Quantitative

Aug 01, 2025
pulisher
Jul 30, 2025

ICON Plc’s Earnings Call: Balancing Achievements and Challenges - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

ICON plc: Initiation of Coverage- Capitalizing On Opportunities in China, A Critical Growth Market! - smartkarma.com

Jul 30, 2025
pulisher
Jul 29, 2025

ICON Plc's Q2 Earnings Call: Balancing Growth and Challenges - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Deutsche Bank Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $210 - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

Leerink Partners Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $240 - 富途牛牛

Jul 29, 2025
pulisher
Jul 28, 2025

ICON plc’s SWOT analysis: navigating challenges in CRO stock landscape By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

ICON plc’s SWOT analysis: navigating challenges in CRO stock landscape - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

ICON's Intrinsic Value Estimated at $278, 33% Undervalued by Current Share Price - AInvest

Jul 28, 2025
pulisher
Jul 27, 2025

Icon price target raised to $225 from $173 at Mizuho - TipRanks

Jul 27, 2025
pulisher
Jul 26, 2025

ICON plc Q2 2025 Financial Results: Revenue Up 0.8%, Net Income Rises 30.7% - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

UBS Raises Icon PLC Price Target to $240, Maintains 'Buy' Rating - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

Icon PLC (ICLR) Q2 Report: Barclays Raises Price Target to $180, Maintains Equal Weight Rating - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

ICON plc Reports Strong Q2 2025 Financial Results - The Globe and Mail

Jul 26, 2025
pulisher
Jul 25, 2025

ICON plc Expands Share Repurchase Program and Resumes COVID Vaccine Study - The Globe and Mail

Jul 25, 2025
pulisher
Jul 25, 2025

ICON plcOrdinary Shares (Nasdaq:ICLR) Stock Quote - FinancialContent

Jul 25, 2025
pulisher
Jul 25, 2025

Evercore Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $240 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $209 to $240 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

Icon PLC (ICLR) Q2 2025 Earnings Call Highlights: Navigating Cha - GuruFocus

Jul 25, 2025
pulisher
Jul 24, 2025

Icon plc's Shares Surge 17.2% Amid Investor Optimism - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Icon Plc Announces Kedrion IVIg 10% Study for Chronic ITP: Market Implications - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Expects $8B in Revenue for Full Year, Driven by Biotech Wins and Pharma Partnerships - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

ICON plc Announces Successful AGM Resolutions - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Stock Surge: Future Safe or Risky? - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

ICON’s Unexpected Surge: What’s Behind the Jump? - timothysykes.com

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery - Benzinga

Jul 24, 2025
pulisher
Jul 24, 2025

A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $170 to $224 - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Icon plc (ICLR) Shares Surge Over 17% Amid Investor Optimism | ICLR Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Icon Plc’s New Study on Kedrion IVIg 10% for Chronic ITP: What Investors Need to Know - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

ICON’s Earnings Beat and Strategic Moves: A Market Outlook - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On ThursdayArrive AI (NASDAQ:ARAI), ASGN (NYSE:ASGN) - Benzinga

Jul 24, 2025
pulisher
Jul 24, 2025

Growth or Bubble? Decoding the Rapid Rise of ICLR Stock - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

Icon PLC Q2 Earnings Exceed Projections with $183 Million ProfitNews and Statistics - IndexBox

Jul 24, 2025
pulisher
Jul 24, 2025

S&P 500 Futures Climb in Premarket Trading; West Pharmaceutical Svcs, Icon PLC Lead - Barron's

Jul 24, 2025
pulisher
Jul 24, 2025

ICON: Lower Guidance Downside & Expanded Repurchase Plan (ICLR) - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

Icon PLC: Q2 Earnings Snapshot - CTPost

Jul 24, 2025
pulisher
Jul 24, 2025

Icon Earnings: Shares Rise 14% on Strong Business Wins Despite Elevated Cancellations - Morningstar

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Announces Results of Annual General Meeting - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

William Blair Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

ICON PLC reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

ICON plc Reports Strong Q2 2025 Financial Results and Updates Guidance - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

ICON PLC earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

SUI Insider Grant: President Gets 4,788 Restricted Shares at $125.06 | ICLR SEC FilingForm 6-K - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

ICON Reports Second Quarter 2025 Results | ICLR Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

ICON's Resilience in a Turbulent Market: A Case for Strategic Investment - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

ICON Announces Results of Annual General Meeting | ICLR Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

ICON Clinical Research Earnings Soar 31% as Business Wins Hit $3B, Expands $1B Buyback Program - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

ICON plc Stock Takes Center Stage. What’s Next? - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc’s Market Surge: Examining Strong Moves - timothysykes.com

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc Emerges as Phase 1 Clinical Trials Leader in New Benchmark Report - StocksToTrade

Jul 22, 2025

Finanzdaten der Icon Plc-Aktie (ICLR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$277.72
price down icon 1.23%
$138.13
price down icon 1.42%
diagnostics_research DGX
$173.00
price down icon 0.16%
diagnostics_research LH
$260.85
price down icon 1.00%
diagnostics_research MTD
$1,221.84
price down icon 1.78%
diagnostics_research IQV
$177.49
price down icon 3.50%
Kapitalisierung:     |  Volumen (24h):